孟魯司特聯(lián)合舒利迭治療支氣管哮喘急性發(fā)作的臨床效果

打開文本圖片集

【摘要】目的：分析孟魯司特聯(lián)合舒利迭對支氣管哮喘急性發(fā)作的臨床效果。方法：選取我院2020年1月—2023年1月的120例支氣管哮喘急性發(fā)作患者，隨機將其分成為兩組。對照組單用舒利迭，觀察組聯(lián)用孟魯司特。結(jié)果：觀察組的有效率明顯高于對照組（P0.05），治療后，兩組的咳嗽、食欲不振、喘憋和呼吸困難評分均明顯降低（P0.05），治療后，兩組的FEV1/FVC、MVV、MMF和PEF均明顯改善（P

【關鍵詞】孟魯司特；舒利迭；急性發(fā)作；支氣管哮喘

Clinical effect of montelukast combined with seretide on acute attack of bronchial asthma

WU Weijuan

The First People ’s Hospital of Longxi County， Dingxi， Gansu 748100， China

【Abstract】Objective：To analyze the clinical effect of montelukast combined with seretide on acute attack of bronchial asthma. Methods：120 patients with acute attack of bronchial asthma in our hospital from January 2020 to January 2023 were randomly divided into two groups. The control group was treated with seretide alone， and the observation group was treated with montelukast. Results：The effective rate of the observation group was significantly higher than that of the control group （P 0.05）. After treatment， the scores of cough， chest and diaphragm fullness， expectoration， inappetence， asthma and dyspnea in the two groups were significantly reduced （P 0.05）， after treatment， FEV1/FVC， MVV， MMF and PEF of the two groups improved significantly （P

【Key Words】Montelukast； Seretide； Acute attack； Bronchial asthma

支氣管哮喘作為一種慢性反復發(fā)作性的氣道炎性疾病，患者主要表現(xiàn)為氣短、劇烈喘息、咳嗽和胸悶等，其發(fā)生可能與變態(tài)反應、氣道慢性炎癥反應、氣道高反應性以及遺傳機制等緊密相關，若未及時治療會引起呼吸抑制，甚至會危及患者的生命[1]。（剩余4092字）